Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 284

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis

Ussia, G. P., Barbanti, M., Petronio, A. S., Tarantini, G., Ettori, F., Colombo, A., Violini, R., Ramondo, A., Santoro, G., Klugmann, S., Bedogni, F., Maisano, F., Marzocchi, A., Poli, A., De Carlo, M., Napodano, M., Fiorina, C., De Marco, F., Antoniucci, D., de Cillis, E., Capodanno, D., Tamburino, C., on behalf of the CoreValve Italian Registry Investigators·2012·European Heart Journal

Abstract

AIMS: The paucity of evidences about the long-term durability of currently available transcatheter prostheses is one of the main issues of transcatheter aortic valve implantation (TAVI). We sought to assess 3-year clinical and echocardiographic outcomes of patients undergoing TAVI with the third generation CoreValve prosthesis (Medtronic Incorporation, MN, USA). METHODS AND RESULTS: From the Italian CoreValve registry, 181 who underwent TAVI from June 2007 to August 2008 and eligible for 3-year follow-up were analysed. All outcomes were defined according to the Valve Academic Research Consortium. All-cause mortality at 1, 2, and 3 years was 23.6, 30.3, and 34.8%, respectively. Cardiovascular death at 1, 2, and 3 years was 11.2, 12.1, and 13.5%, respectively. The actuarial survival free from a composite of death, major stroke, myocardial infarction, and life-threatening bleeding was 69.6% at 1 year, 63.5% at 2 years, and 59.7% at 3 years. Patients with renal insufficiency had a higher mortality at 3-year follow-up (49.0 vs. 29.2%, P = 0.007); moreover, patients experiencing post-procedural major or life-threatening bleeding had a higher rate of mortality already seen at 30 days (21.6 vs. 2.8%; P < 0.001) and this result was sustained at 3-year follow-up (62.2 vs. 27.7%; P < 0.001). Mean pressure gradients decreased from 52.2 ± 18.1 mmHg (pre-TAVI) to 10.3 ± 3.1 mmHg (1-year post-TAVI) (P < 0.001); aortic valve area increased from 0.6 ± 0.2 cm(2) (pre-TAVI) to 1.8 ± 0.4 cm(2) (1-year post-TAVI); these results remained stable over the 3 years of follow-up. Paravalvular leak was observed in the majority of patients. There were no cases of progression to moderate or severe regurgitation. No cases of structural valve deterioration were observed. CONCLUSION: This multicentre study demonstrates that TAVI with the 18-Fr CoreValve ReValving System is associated with sustained clinical and functional cardiovascular benefits in high-risk patients with symptomatic aortic stenosis up to 3-year follow-up. Non-cardiac causes accounted for the majority of deaths at follow-up.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehr491

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 284

Metadata

Authors
Ussia, G. P., Barbanti, M., Petronio, A. S., Tarantini, G., Ettori, F., Colombo, A., Violini, R., Ramondo, A., Santoro, G., Klugmann, S., Bedogni, F., Maisano, F., Marzocchi, A., Poli, A., De Carlo, M., Napodano, M., Fiorina, C., De Marco, F., Antoniucci, D., de Cillis, E., Capodanno, D., Tamburino, C., & on behalf of the CoreValve Italian Registry Investigators
Venue
European Heart Journal
Published
2012-01-12
Volume
33
Issue
8
Pages
969-976
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2110226194
Cited by
284
References
4
FWCI
36.45
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. https://app.cochat.ai/papers/10.1093/eurheartj/ehr491
The paper
Ussia, G. P., Barbanti, M., Petronio, A. S., Tarantini, G., Ettori, F., Colombo, A., Violini, R., Ramondo, A., Santoro, G., Klugmann, S., Bedogni, F., Maisano, F., Marzocchi, A., Poli, A., De Carlo, M., Napodano, M., Fiorina, C., De Marco, F., Antoniucci, D., . . . on behalf of the CoreValve Italian Registry Investigators. (2012). Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. European Heart Journal. https://doi.org/10.1093/eurheartj/ehr491

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.